<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="41076">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02571647</url>
  </required_header>
  <id_info>
    <org_study_id>RC15_0219</org_study_id>
    <nct_id>NCT02571647</nct_id>
  </id_info>
  <brief_title>Evaluation of Screening for Visual Disorders of the Old Subject in Consultation Memory</brief_title>
  <acronym>EVAM</acronym>
  <official_title>Evaluation of Screening for Visual Disorders of the Old Subject in Consultation Memory</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nantes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Visual disorders are often overlooked in the treatment of cognitive disorders of the
      elderly. Yet the visual deficit impacts the quality of life, the evolution of the autonomy
      and psycho-behavioral disorders in cognitive diseases. The main objective of the study is to
      evaluate the prevalence of visual disorders among elderly patients at consultant outpatient
      center of Nantes clinical gerontology as part of the consultation geriatric memory.
      Secondary objectives are to describe ophthalmological diseases detected and taken into the
      proposed ophthalmic load, to determine if there are associations between eye diseases and
      cognitive disorders, to estimate the proportion of patients who may have an ophthalmologic
      evaluation to determine the cognitive profiles and geriatric evaluation and ocular
      pathological, depending on the assessment of arterial stiffness. The results of this study
      will build a testing strategy to promote access of older patients with cognitive impairment
      to vision care.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">July 2017</completion_date>
  <primary_completion_date type="Actual">January 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants with presence of an ophthalmological disease (symptomatic or not) after clinical evaluation.</measure>
    <time_frame>6 month</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Visual Disorders</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Non interventional study</intervention_name>
    <description>Patients agreeing to participate in the study will have a cognitive assessment and geriatric assessment, carried out according to usual practices and grids clinical gerontology cluster.
They will benefit in addition to a noninvasive screening and risk-free ophthalmic (visual acuity, intraocular pressure, examination of the eyelids and fundus).</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients eligible for the study will be all patients 65 and older, in consultation from
        memory or day hospital Clinical Gerontology ambulatory center at Nantes University
        Hospital.

        Geriatrician who will see the patient Clinical Gerontology ambulatory center be informed
        of the study and gather written consent and that of his legal representative, if
        applicable.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Elderly over 65 years,

          -  Subject to consultation from memory Clinical Gerontology ambulatory center Nantes
             University Hospital

          -  Current use of spoken French

          -  Patient (or legal guardian, if applicable) has given its written consent

          -  Patient affiliated to a social security scheme

        Exclusion Criteria:

          -  Life expectancy lower 1 year

          -  Mobility limitation preventing the installation retinal

          -  Major disorders and productive behavior does not allow participation in diagnostic
             procedures.

          -  Inability to respond to instructions when performing ophthalmological examinations.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gilles BERRUT, Pr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nantes University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gilles BERRUT, Pr</last_name>
    <phone>02 40 68 66 72</phone>
    <email>gilles.berrut@chu-nantes.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Nantes University Hospital</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pascal CHEVALET, Dr</last_name>
      <email>pascal.chevalet@chu-nantes.fr</email>
    </contact>
    <investigator>
      <last_name>Pascal CHEVALET, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nantes University Hospital</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sophie PICHIERRI, Dr</last_name>
      <email>sophie.pichierri@chu-nantes.fr</email>
    </contact>
    <investigator>
      <last_name>Sophie PICHIERRI, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nantes University Hospital</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Typhaine RIAUDEL, Dr</last_name>
      <email>typhaine.riaudel@chu-nantes.fr</email>
    </contact>
    <investigator>
      <last_name>Typhaine RIAUDEL, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nantes University Hospital</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie-Hélène Fix, Dr</last_name>
      <email>mariehelene.fix@chu-nantes.fr</email>
    </contact>
    <investigator>
      <last_name>Marie-Hélène Fix, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nantes University Hospital</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hélène MASSE, Dr</last_name>
      <email>helene.masse@chu-nantes.fr</email>
    </contact>
    <investigator>
      <last_name>Hélène MASSE, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <lastchanged_date>March 22, 2016</lastchanged_date>
  <firstreceived_date>October 5, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Vision Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
